Gainers
- CNS Pharma CNSP stock moved upwards by 143.7% to $0.38 during Wednesday's pre-market session. The market value of their outstanding shares is at $12.2 million.
- DBV Technologies DBVT stock increased by 62.87% to $1.14. The market value of their outstanding shares is at $109.6 million.
- Cyclacel Pharmaceuticals CYCC shares increased by 46.15% to $2.09. The company's market cap stands at $4.1 million.
- Mustang Bio MBIO shares moved upwards by 34.59% to $0.38. The market value of their outstanding shares is at $14.1 million.
- LakeShore Biopharma LSB shares moved upwards by 25.49% to $3.2. The market value of their outstanding shares is at $61.0 million.
- BioVie BIVI shares increased by 19.34% to $4.01. The company's market cap stands at $32.0 million.
Losers
- Alto Neuroscience ANRO stock decreased by 62.3% to $5.48 during Wednesday's pre-market session. The company's market cap stands at $147.7 million.
- Ensysce Biosciences ENSC shares declined by 18.58% to $0.44. The market value of their outstanding shares is at $6.0 million.
- Genprex GNPX stock declined by 14.49% to $3.07. The company's market cap stands at $7.9 million.
- TELA Bio TELA stock decreased by 14.46% to $2.13. The company's market cap stands at $52.6 million.
- Aptevo Therapeutics APVO stock fell 12.7% to $0.31. The market value of their outstanding shares is at $4.1 million.
- Creative Medical Tech CELZ stock decreased by 11.51% to $4.0. The company's market cap stands at $5.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
APVOAptevo Therapeutics Inc
$4.775.76%
BIVIBioVie Inc
$2.261.35%
CELZCreative Medical Technology Holdings Inc
$2.06-5.50%
CNSPCNS Pharmaceuticals Inc
$0.1028-5.51%
CYCCCyclacel Pharmaceuticals Inc
$0.36794.40%
DBVTDBV Technologies SA
$4.40-10.4%
ENSCEnsysce Biosciences Inc
$7.324.57%
GNPXGenprex Inc
$0.72002.86%
LSBLakeShore Biopharma Co Ltd
$2.29-2.35%
MBIOMustang Bio Inc
$5.22-11.2%
TELATELA Bio Inc
$2.691.13%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in